0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Pathological Case of the Month FREE

Arch Pediatr Adolesc Med. 1998;152(5):510. doi:.
Text Size: A A A
Published online

DIAGNOSIS AND DISCUSSION: PRIMARY HEPATIC MALIGNANT TUMOR WITH RHABDOID FEATURES

Figure 1. Abdominal computed tomographic scan showing a large hypodense liver mass with irregular calcifications.

Figure 2. A solid sheet of round to polygonal cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm (hematoxylin-eosin, original magnification ×100).

Figure 3. Neoplastic cells demonstrate an intense intracytoplasmic immunoexpression for vimentin (peroxidase, original magnification ×100). Epithelial membrane antigen was expressed and no reaction to muscle specific actin cytokeratins, and S100 proteins were noted.

Figure 4. Electron microscopy showing a rhabdoid cell with large nucleoli and paranuclear aggregates of intermediate filaments (original magnification ×3900).

Exploratory laparotomy with tumor biopsy was performed (Figure 2 and Figure 3). Neoplastic cells also expressed epithelial membrane antigen. An ultrastructural study was also performed (Figure 4).

Rhabdoid tumor was originally described as a distinctive, highly malignant renal neoplasm of the infant.1,2 Extrarenal rhabdoid tumors, like those arising in the kidney, usually present in early infancy and have an aggressive behavior. Nevertheless, it is unclear whether extrarenal rhabdoid tumors are only "pseudorhabdoid" and represent a morphologic phenotype or whether they really are distinct clinicopathologic entities.24 The histogenesis of these tumors remains unknown, and the term primitive malignant tumor with rhabdoid features (MTR) was introduced to describe neoplasms with a rhabdoid phenotype, particularly those occurring outside the kidney.4,5

Primary hepatic MTR are rare, and less than 20 cases have been reported.6 They present in early infancy, as an abdominal mass. Hepatic MTR, α1-fetoprotein levels are normal. Unlike hepatoblastoma, do not respond to treatment and have an ominous prognosis. Pathological diagnostic features include: (1) Sheets of large polygonal cells with eccentric vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm; (2) Immunohistochemical expression of vimentin and epithelial markers and sometimes other antigens; and (3) Ultrastructural demonstration of cytoplasmic inclusions composed of whorled intermediate filaments.

Hypercalcemia, although rarely associated, is a well-established complication of renal rhabdoid tumors.79 It is not caused by bony metastases but may be caused by neoplastic cells' secretion of parathyroid hormone, parathyroid hormone-like proteins, or prostaglandins. Hypercalcemia was a constant laboratory finding in our patient. The reason for the hypercalcemia was unrelated to skeletal metastases and serum levels of immunoreactive parathyroid hormone, calcitriol, and vitamin D were within normal limits. We were unable to find a similar phenomenon in the 18 previously reported cases of hepatic MTR.

Hepatoblastoma and hepatocarcinoma account for most malignant hepatic tumors of children. Both neoplasms, as well as the less common undifferentiated embryonal sarcoma and rhabdomyosarcoma, have been well-characterized cytologically.10 However, no previous cytologic reports concerning hepatic MTR are available. Our cytologic findings were identical to those reported in rhabdoid tumor of the kidney.9 So identical, that the possibility of a metastasizing renal tumor should always be considered and a renal scan should always be performed. Although hepatic MTR is rare, we believe that cytologic findings are characteristic enough to permit its recognition. A specific diagnosis is only obtained after immunohistochemical and ultrastructural evaluation. The decision whether primary hepatic or metastatic tumor is present requires a complete clinical and physical examination of the patient.

Hepatic MTR is an uncommon neoplasm with distinct pathological features. It should enter the differential diagnosis of pediatric primary hepatic tumors with normal levels of α1-fetoprotein and of malignant neoplasms associated with hypercalcemia. Whether it represents a well-defined clinicopathologic entity remains unknown. However, its recognition is important since it does not respond to therapy and its prognosis is fatal.

Accepted for publication February 1, 1997.

From the Department of Pathology, University Hospital La Paz, Madrid, Spain.

Corresponding author: José A. Jiménez-Heffernan, MD, Departamento de Anatomía Patológica, Hospital La Paz, Paseo de La Castellana 261, 28046-Madrid, Spain.

Beckwith  JBPalmer  NF Histopathology and prognosis of Wilms' tumors: results from the First National Wilms' Tumor Study. Cancer. 1978;411937- 1948
Link to Article
Parham  DMWeeks  DABeckwith  JB The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. Am J Surg Pathol. 1994;181010- 1029
Link to Article
Weeks  DABeckwith  JBMierau  GW Rhabdoid tumor: an entity or a phenotype? Arch Pathol Lab Med. 1989;113113- 114
Berry  JVujanic  GM Malignant rhabdoid tumor. Histopathology. 1992;20189- 193
Link to Article
Gafney  EFBreatnach  F Diverse immunoreactivity and metachronous ultrasound variability in fatal primitive childhood tumor with rhabdoid features. Arch Pathol Lab Med. 1989;1131322
Scheimberg  ICullinane  CKelsey  AMalone  M Primary hepatic malignant tumor with rhabdoid features. Am J Surg Pathol. 1996;201394- 1400
Link to Article
Mayes  LCKasselberg  AGRoloff  JSLukens  JN Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms' tumor). Cancer. 1984;54882- 884
Link to Article
Gururangan  SBowman  LCParham  DM  et al.  Primary extracranial rhabdoid tumors: clinicopathologic features and response to ifosfamide. Cancer. 1993;712653- 2659
Link to Article
Drut  R Malignant rhabdoid tumor of the kidney diagnosed by fine needle aspiration cytology. Diagn Cytopathol. 1990;6124- 126
Link to Article
Pitman  MBSzyfelbein  WM Fine Needle Aspiration Biopsy of the Liver.  Newton, Mass Butterworth-Heinemann1994;

Tables

References

Beckwith  JBPalmer  NF Histopathology and prognosis of Wilms' tumors: results from the First National Wilms' Tumor Study. Cancer. 1978;411937- 1948
Link to Article
Parham  DMWeeks  DABeckwith  JB The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. Am J Surg Pathol. 1994;181010- 1029
Link to Article
Weeks  DABeckwith  JBMierau  GW Rhabdoid tumor: an entity or a phenotype? Arch Pathol Lab Med. 1989;113113- 114
Berry  JVujanic  GM Malignant rhabdoid tumor. Histopathology. 1992;20189- 193
Link to Article
Gafney  EFBreatnach  F Diverse immunoreactivity and metachronous ultrasound variability in fatal primitive childhood tumor with rhabdoid features. Arch Pathol Lab Med. 1989;1131322
Scheimberg  ICullinane  CKelsey  AMalone  M Primary hepatic malignant tumor with rhabdoid features. Am J Surg Pathol. 1996;201394- 1400
Link to Article
Mayes  LCKasselberg  AGRoloff  JSLukens  JN Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms' tumor). Cancer. 1984;54882- 884
Link to Article
Gururangan  SBowman  LCParham  DM  et al.  Primary extracranial rhabdoid tumors: clinicopathologic features and response to ifosfamide. Cancer. 1993;712653- 2659
Link to Article
Drut  R Malignant rhabdoid tumor of the kidney diagnosed by fine needle aspiration cytology. Diagn Cytopathol. 1990;6124- 126
Link to Article
Pitman  MBSzyfelbein  WM Fine Needle Aspiration Biopsy of the Liver.  Newton, Mass Butterworth-Heinemann1994;

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Cancer, Family History

The Rational Clinical Examination
Original Article: Does This Patient Have a Family History of Cancer?